3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
12
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
10
Lymphoma, Non-Hodgkin
7
Lymphoma, Follicular
6
Lymphoma
5
Lymphoma, Large B-Cell, Diffuse
3
Recurrence
2
Lymphoma, B-Cell, Marginal Zone
2
Arthritis, Rheumatoid
2
Off-Label Use
1
Lymphoma, Mantle-Cell
1
Leukemia, B-Cell
1
Infections
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Interventions
Watchful Waiting
2
Blood Specimen Collection
2
Vital Signs
1
Specimen Handling
1
Rituximab
1
Observation
1
Interviews as Topic
1
Flow Cytometry
1
Filgrastim
1
Data Collection
1
COVID-19 Vaccines
1
Bortezomib
1
Blood Viscosity
1
Albumins
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Hematologic Diseases
×
Rituximab
×
Clear all
NCT07200583
2025-11-18
PAIA-Haplo
Fujian Medical University
Completed
50 enrolled